Jesduvroq

Indicated For

anemia due to chronic kidney disease (CKD) in adults on dialysis

About This Medication

# GlaxoSmithKline Patient Assistance Program: How to Get Jesduvroq at Low or No Cost ## Important Notice As of 2026, **GlaxoSmithKline (GSK) has withdrawn Jesduvroq (daprodustat) from the US market**. This medication is no longer available for new prescriptions in the United States. If you were previously taking Jesduvroq, please consult with your nephrologist about alternative treatment options for anemia due to chronic kidney disease. This guide is provided for historical reference only. For current assistance with CKD anemia medications, please contact your healthcare provider or explore other patient assistance programs. --- ## About Jesduvroq (daprodustat) Jesduvroq was an oral medication approved by the FDA in February 2023 for treating anemia in adults with chronic kidney disease (CKD) who have been receiving dialysis for at least four months. It was the first oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) approved in the United States, offering a tablet-based alternative to injectable treatments. The medication worked by stabilizing hypoxia-inducible factors, which stimulated the body's natural production of erythropoietin—similar to the physiological response that occurs at high altitude. This mechanism helped increase red blood cell production and reduce the need for blood transfusions. ## Why This Program Is No Longer Available GSK made the strategic decision to withdraw Jesduvroq from the US market after its initial approval. This decision may have been influenced by various commercial, regulatory, or clinical considerations. Patients who were benefiting from this medication should work with their healthcare team to transition to alternative therapies. ## Alternative Treatment Options If you have anemia due to CKD and were taking Jesduvroq, your nephrologist may recommend: - **Erythropoiesis-stimulating agents (ESAs)**: Injectable medications that stimulate red blood cell production - **Iron supplementation**: To address iron deficiency anemia - **Red blood cell transfusions**: For severe anemia cases - **Other HIF-PHI medications**: If approved and available through your insurance ## Finding Financial Assistance for CKD Medications If you need help affording CKD medications, several resources are available: **PAN Foundation CKD Copay Assistance**: The Patient Advocate Foundation offers up to $4,800 per year in copay assistance grants for chronic kidney disease medications. This program may help with alternative treatments your doctor prescribes. **Medicare Prescription Payment Plan**: If you have Medicare Part D coverage, you may be eligible for the Medicare Prescription Payment Plan, which allows you to spread medication costs over time. **GoodRx and Similar Discount Programs**: These services can provide discounts on many medications, including alternatives to Jesduvroq. **Manufacturer Assistance Programs**: Other pharmaceutical companies producing CKD anemia treatments may offer patient assistance programs with income-based eligibility. ## What to Do Next 1. **Contact your nephrologist** to discuss alternative medications for your anemia 2. **Ask about patient assistance programs** for any new medication prescribed 3. **Explore Medicare or insurance options** if you have coverage 4. **Call the PAN Foundation** at their CKD program line for copay assistance with approved alternatives 5. **Check GoodRx or similar platforms** for discount codes on prescribed medications ## Important Disclaimer This guide is provided for informational purposes only and does not constitute medical advice. Jesduvroq is no longer available in the US market as of 2026. All treatment decisions should be made in consultation with your healthcare provider. Income eligibility, application procedures, and program requirements for alternative medications vary by program and change over time. Always verify current program details directly with the program administrator or your healthcare provider before applying. --- **Need Help?** Contact your nephrologist's office or call the PAN Foundation at their chronic kidney disease program line for assistance locating current patient support programs for your prescribed CKD anemia treatment.

Program information last verified: March 30, 2026